Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica - Wikidata - awgldk - TriplyDB

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

http://www.wikidata.org/entity/Q35891629

about

Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases.The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status.Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases.

P2860

Q21131133-865ADE97-2553-4EF4-923A-66E72CD1F520 Q35013894-DCA211D6-9073-4B82-81C3-709E4854E9B2 Q36178032-688128C7-415E-4BED-A73B-A1AC11540115 Q36646919-FE3475B8-3621-4479-AB20-78E4BA7BD134 Q36842571-FC0CA2AF-8905-4C11-BE4B-9A1A07D56220 Q37076685-2D86C897-96F3-4761-8CA2-CD826972B6B7 Q37639788-25F96F61-D18F-41B6-926A-691F8E7E8571 Q38940579-CA69B9AB-50C1-4EA2-8D61-F4BD3FB92043 Q39095729-D8BA37B9-E178-4151-9C79-18A7B11980F0 Q40307719-15AE7669-B0A4-4D8B-8B9D-9EB45A2951BC Q41680441-3C6CD59C-D5EE-4185-8246-7F1966A2EE2B Q55039421-4B940FC6-680E-4AD8-A85B-EB0F2751BC12

P2860

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

http://www.wikidata.org/entity/Q35891629

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@ast

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@en

type

label

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@ast

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@en

prefLabel

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@ast

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@en

P1433

Q35891629-9237DA0D-8E1A-4753-8F02-C4F2DB54F0DF

P1476

Q35891629-C8ED7A1E-4216-4227-B597-4272CA799F2C

P2093

Q35891629-16450982-32AC-4F92-87E9-94524D4342A1

Q35891629-243106BC-7B89-45C6-B204-965D4D104FC7

Q35891629-3909C4C9-BC9F-493D-92AF-7E3B027A3CE9

Q35891629-65561CEE-26BC-447F-A1C9-AF24190F647C

Q35891629-9F927C19-21B6-4BF6-B997-4B34FD313AAD

P2860

Q35891629-0481F3E8-442D-4FDD-A109-2E888EA2FA10

Q35891629-1202BE4C-A005-47DC-B61F-0104CEE26F79

Q35891629-121E9494-D073-45C7-94A2-D53824B4570A

Q35891629-145E697A-742D-4D53-8C32-64BB9B9F201D

Q35891629-1EC45184-CFB3-42FB-8671-EEBFA0A55AA3

Q35891629-2C86208A-4959-40C0-9271-34711AB46F14

Q35891629-47B93C9A-C921-45F9-BE25-5D0B6E3858BC

Q35891629-4CB5ABFE-19E5-4D40-A23A-27781622BAA2

Q35891629-51C237EC-4EDD-4EFC-AE35-B668ABAA08B1

Q35891629-57BF9D74-26D7-4D74-8E50-6AE002AC2B54

P304

Q35891629-3A418E30-DFAD-4774-BA06-735CC69B2A54

P31

Q35891629-2D3E439A-DEFC-4549-B1B5-9CC798516A9A

P356

Q35891629-E275C3EA-0E58-416B-8F98-BE3DBCD1B21D

P407

Q35891629-820B67D9-AD5F-4205-8002-7DEFCF3902FE

P433

Q35891629-76C0C0D1-4DD3-49DA-95FF-96E302C7EE53

P478

Q35891629-7BBC1A03-6406-48F9-8506-189522D18E22

P577

Q35891629-A3992D3E-0802-4F10-9FA2-862E1334A183

P5875

Q35891629-1CB01714-E13A-4BC0-B62D-44B6C0C6868D

P698

Q35891629-8B9002C1-B353-467C-BAA9-50719984FEE6

P921

Q35891629-9ED9B6BB-938A-42ED-AB1F-9E181ACAF927

P932

Q35891629-4B5BDD14-DD3F-407E-9D9A-C23B85F6E27F

P356

BLOOD-2011-11-390807

P1433

P1476

Quantitative differences in HT ...... HAM/TSP patients from Jamaica

@en

P2093

Anna Abrams

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Maloney

http://www.w3.org/2001/XMLSchema#string

Kory R Johnson

http://www.w3.org/2001/XMLSchema#string

Steven Jacobson

http://www.w3.org/2001/XMLSchema#string

Yoshimi Enose-Akahata

http://www.w3.org/2001/XMLSchema#string

P2860

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.

Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

Antibody-profiling technologies for studying humoral responses to infectious agents.

LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV.

Global epidemiology of HTLV-I infection and associated diseases.

In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies

P304

2829-2836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-11-390807

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221817166

http://www.w3.org/2001/XMLSchema#string

P698

22318200

http://www.w3.org/2001/XMLSchema#string

P921

Human T-lymphotropic virus 1

P932

3327461

http://www.w3.org/2001/XMLSchema#string